Triplet Therapeutics Investors

21 investors on Angel Roster list Triplet Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States.

Investors are matched on the company name in their portfolio, so companies that share the name Triplet Therapeutics can appear together.

Investors listed
21
With verified email
48%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 21 Triplet Therapeutics investors

The most complete profiles first. Showing 21 of 21.

  • Jernej GodecVerified

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more

    Verified email available

  • Kevin BittermanVerified

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 70 more

    Verified email available

  • Meredith FisherVerified

    Venture Capital, Investor · United States

    SeedHealth CareWellnessWomen FoundedLife Science

    Portfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more

    Verified email available

  • Roger KittermanVerified

    Venture Capital, Investor · United States

    SeedHealth CareWellnessWomen FoundedLife Science

    Portfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more

    Verified email available

  • Alex HardingVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more

    Verified email available

  • Brian GoodmanVerified

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Jason RhodesVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more

    Verified email available

  • Luke EvninVerified

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Shinichiro FuseVerified

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Todd FoleyVerified

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Carl Berke

    Venture Capital, Investor · United States

    SeedHealth CareWellnessWomen FoundedLife Science

    Portfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more

    Contact details available

  • Ed Hurwitz

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, Protego Biopharma, InformedDNA, Mitobridge and 60 more

    Contact details available

  • Stephen Curtis

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Christiana Bardon M.D.

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Health CareGeneticsInvestment ManagementLife Science

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Jean

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more

    Contact details available

  • Jonathan Kabakoff

    Corporate Venture Capital · United States

    Health CareWomen FoundedChemicalLife Science

    Portfolio: Molecular Assemblies, Syros Pharmaceuticals, EpiBiome, Immunitas Therapeutics and 30 more

    Contact details available

  • Julius Knowles

    Venture Capital, Design Operator, Strategy Operator · United States

    Health CareHospitalsWellnessWomen Founded

    Portfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more

    Contact details available

  • Leigh Zawel

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Ruoxi Hu

    Venture Capital · United States

    Health CareWellnessWomen FoundedLife Science

    Portfolio: CoStim Pharmaceuticals, Magenta Therapeutics, ImmuneXcite, InStore Finance and 23 more

    Contact details available

  • Steven Robinette

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more

    Contact details available

  • Vinay Bhaskar

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

Frequently asked questions

How many Triplet Therapeutics investors are on Angel Roster?

Angel Roster lists 21 Triplet Therapeutics investors. 10 of them (48%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (20), Private Equity Firms (10) and Investment Partner Investors (3). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Triplet Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (5) and Series B (2).

Where are Triplet Therapeutics investors based?

Most are based in the United States (21).

Which companies have Triplet Therapeutics investors backed?

The most-backed portfolio companies among them are Raze Therapeutics (20), Dyne Therapeutics (15), CoStim Pharmaceuticals (14), Translate Bio (11) and Spero Therapeutics (11).

How do I contact Triplet Therapeutics investors?

Create a free Angel Roster account to search and filter all 21, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.